Wealth Enhancement Advisory Services’s Pulmonx LUNG Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.8K	Buy	+23,233	New	+$32K	﹤0.01%	3967

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Wealth Enhancement Advisory Services's LUNG Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Pulmonx (LUNG) in Q2 2026: 23,233 shares worth $35.8K. The stake represents ﹤0.01% of the portfolio and ranks #3967 among its holdings.

107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Wealth Enhancement Advisory Services held 23,233 shares of Pulmonx worth $35.8K as of Q2 2026.
Pulmonx was a new Wealth Enhancement Advisory Services position in Q2 2026.
Pulmonx made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3967 holding.
107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.